rs4730751

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001753.5(CAV1):​c.195+14107C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.217 in 152,050 control chromosomes in the GnomAD database, including 3,903 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.22 ( 3903 hom., cov: 32)

Consequence

CAV1
NM_001753.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.822

Publications

26 publications found
Variant links:
Genes affected
CAV1 (HGNC:1527): (caveolin 1) The scaffolding protein encoded by this gene is the main component of the caveolae plasma membranes found in most cell types. The protein links integrin subunits to the tyrosine kinase FYN, an initiating step in coupling integrins to the Ras-ERK pathway and promoting cell cycle progression. The gene is a tumor suppressor gene candidate and a negative regulator of the Ras-p42/44 mitogen-activated kinase cascade. Caveolin 1 and caveolin 2 are located next to each other on chromosome 7 and express colocalizing proteins that form a stable hetero-oligomeric complex. Mutations in this gene have been associated with Berardinelli-Seip congenital lipodystrophy. Alternatively spliced transcripts encode alpha and beta isoforms of caveolin 1.[provided by RefSeq, Mar 2010]
CAV1 Gene-Disease associations (from GenCC):
  • pulmonary arterial hypertension
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • pulmonary hypertension, primary, 3
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • congenital generalized lipodystrophy type 3
    Inheritance: AD, AR Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, G2P
  • heritable pulmonary arterial hypertension
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Berardinelli-Seip congenital lipodystrophy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.25 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CAV1NM_001753.5 linkc.195+14107C>A intron_variant Intron 2 of 2 ENST00000341049.7 NP_001744.2
CAV1NM_001172895.1 linkc.102+14107C>A intron_variant Intron 2 of 2 NP_001166366.1
CAV1NM_001172896.2 linkc.102+14107C>A intron_variant Intron 1 of 1 NP_001166367.1
CAV1NM_001172897.2 linkc.102+14107C>A intron_variant Intron 2 of 2 NP_001166368.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CAV1ENST00000341049.7 linkc.195+14107C>A intron_variant Intron 2 of 2 1 NM_001753.5 ENSP00000339191.2

Frequencies

GnomAD3 genomes
AF:
0.217
AC:
32951
AN:
151932
Hom.:
3906
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.201
Gnomad AMI
AF:
0.317
Gnomad AMR
AF:
0.190
Gnomad ASJ
AF:
0.349
Gnomad EAS
AF:
0.0104
Gnomad SAS
AF:
0.203
Gnomad FIN
AF:
0.130
Gnomad MID
AF:
0.307
Gnomad NFE
AF:
0.254
Gnomad OTH
AF:
0.242
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.217
AC:
32949
AN:
152050
Hom.:
3903
Cov.:
32
AF XY:
0.209
AC XY:
15516
AN XY:
74322
show subpopulations
African (AFR)
AF:
0.201
AC:
8326
AN:
41464
American (AMR)
AF:
0.189
AC:
2888
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.349
AC:
1210
AN:
3472
East Asian (EAS)
AF:
0.0104
AC:
54
AN:
5170
South Asian (SAS)
AF:
0.203
AC:
978
AN:
4820
European-Finnish (FIN)
AF:
0.130
AC:
1379
AN:
10586
Middle Eastern (MID)
AF:
0.296
AC:
87
AN:
294
European-Non Finnish (NFE)
AF:
0.254
AC:
17234
AN:
67956
Other (OTH)
AF:
0.239
AC:
504
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1332
2664
3996
5328
6660
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
350
700
1050
1400
1750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.226
Hom.:
499
Bravo
AF:
0.222
Asia WGS
AF:
0.0940
AC:
331
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
8.0
DANN
Benign
0.58
PhyloP100
0.82
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4730751; hg19: chr7-116180850; API